Ensuring that life-saving doses are available to countries most in need, rather than merely to those with the deepest pockets, is a moral imperative and self-interest for every nation.
Achieving equitable vaccine distribution requires substantial financial contributions and significant concessions from pharmaceutical firms, yet discussions continue to stall without resolution.
The WHO declared the mpox outbreak a public health emergency of international concern as cases spread, particularly in the DRC, highlighting the severe consequences of inaction.
Despite significant concerns over the new mpox strain, many nations remain preoccupied with local matters, allowing the virus to proliferate unchecked in affected regions.
Collection
[
|
...
]